Chemical Structure (Dutasteride 01)
Dutasteride Capsule
Product Images NDC 84091-100
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Dutasteride (NDC 84091-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Banyan Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Dutasteride 02)
Figure 2 (Dutasteride 03)
Figure 3 (Dutasteride 04)
This is a comparison of the effectiveness of a placebo group versus a Dutasteride group over a 24-month treatment period. The data shows the number of events cumulated over time and the number at risk in each group. This information is useful for evaluating the impact of Dutasteride on the given conditions being studied.*
Figure 4 (Dutasteride 05)
Figure 5 (Dutasteride 06)
Figure 6 (Dutasteride 07)
Figure 7 (Dutasteride 08)
Principal Display Panel (90 Capsule Bottle Carton)
This text provides information regarding Dutasteride capsules, a prescription medication used for treating certain conditions. It warns against use by women or children, especially those who are pregnant or may become pregnant. Patients are advised to swallow the capsules whole, store them properly, and consult the prescribing information for dosage instructions. Additionally, it highlights safety precautions and what to do in case of contact with a leaking capsule.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
